Infographic: Sequencing BTK inhibitors in the Treatment of B-Cell Malignancies
This infographic highlights the role of non-covalent BTK inhibitors in addressing limitations of toxicity, acquired resistance, and providing treatment options for patients with MCL or CLL after failure on covalent BTK inhibitors and BCL-2 inhibitors.
Date of Last Review: January 30, 2025
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice